News
Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around ...
Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
11h
Zacks.com on MSNPfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line GrowthPFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost ...
StockStory.org on MSN17h
Pfizer (NYSE:PFE) Reports Upbeat Q2Global pharmaceutical company Pfizer (NYSE:PFE) announced in Q2 CY2025, with sales up 10.3% year on year to $14.65 billion.
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...
Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year ...
Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...
16h
InvestorsHub on MSNPfizer lifts 2025 profit forecast after strong Q2 beats, shares risePfizer (NYSE:PFE) raised its full-year earnings outlook on Tuesday after reporting second-quarter results that surpassed Wall ...
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
Pfizer expects full-year earnings in the range of $2.90 to $3.10 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...
Pfizer (PFE) stock is moving higher after beating Wall Street expectations for the second quarter and raising its full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results